<scp>IRG1</scp> restrains <scp>M2</scp> macrophage polarization and suppresses intrahepatic cholangiocarcinoma progression via the <scp>CCL18</scp>/<scp>STAT3</scp> pathway
Menghua Zhou, Hongjun Yu, Miaoyu Bai, Shounan Lu, Chaoqun Wang, Shanjia Ke, Jingjing Huang, Zihao Li, Yanan Xu, Bing Yin, Xinglong Li, Zhigang Feng, Yao Fu, Hongchi Jiang, Yong Ma
Abstract
Intrahepatic cholangiocarcinoma (ICC) is a highly malignant and aggressive cancer whose incidence and mortality continue to increase, whereas its prognosis remains dismal. Tumor-associated macrophages (TAMs) promote malignant progression and immune microenvironment remodeling through direct contact and secreted mediators. Targeting TAMs has emerged as a promising strategy for ICC treatment. Here, we revealed the potential regulatory function of immune responsive gene 1 (IRG1) in macrophage polarization. We found that IRG1 expression remained at a low level in M2 macrophages. IRG1 overexpression can restrain macrophages from polarizing to the M2 type, which results in inhibition of the proliferation, invasion, and migration of ICC, whereas IRG1 knockdown exerts the opposite effects. Mechanistically, IRG1 inhibited the tumor-promoting chemokine CCL18 and thus suppressed ICC progression by regulating STAT3 phosphorylation. The intervention of IRG1 expression in TAMs may serve as a potential therapeutic target for delaying ICC progression.